Angiotensin converting enzyme deletion allele in different kinds of dementia disorders

Neuroscience Letters

Volumn 267, Issue 2, 1999, Pages 97-100

  Palumbo, Barbara ^a   Cadini, Donatella ^a   Nocentini, Giuseppe ^a   Filipponi, Enrica ^b   Fravolini, Mario L ^b   Senin, Umberto ^a  

^a Dept Clin Med Pathol P ^*  (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Age associated memory impairment; Aging brain; Alzheimer's disease; Angiotensin converting enzyme gene; Apolipoprotein E genotype; Cognitive impairment; Dementia; Renin angiotensin system

Indexed keywords

APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; ONSET AGE; PRIORITY JOURNAL; SENILE DEMENTIA;

AGE FACTORS; AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; DEMENTIA; FEMALE; GENE DELETION; GENOTYPE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A;

EID: 0033612161     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00329-8     Document Type: Article

References (17)

1. Amoyel P., Richard F., Cottel D., Amant C., Codron V., Helbecque N. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci. Lett. 217:1996;203-205.
2. Arbustini E., Grasso M., Fasani R., Klersy C., Diegoli M., Porcu E., Banchieri N., Fortina P., Danesino C., Specchia G. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br. Heart J. 74:1995;584-591.
3. Barnes N.M., Cheng C.H., Costall B., Naylor R.J., Williams T., Wischik C.M. Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease. Eur. J. Pharmacol. 20:1991;289-292.
4. Bisani M.L., Clementi S., Wold S. La chimica e l'Industria. 1982;Società Chimica Italiana, Roma. pp. 655-665/727-741.
5. Castellano M., Muiesan M.L., Rizzoni D., Beschi M., Pasini G., Cinelli A., Salvetti M., Porteri E., Bettoni G., Krentz R., Lindpainter K., Agabiti Rosei E. Angiotensin converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation. 91:1995;2721-2724.
6. Croog S.H., Levine S., Testa M.A., Brown B., Bulpitt C.J., Jenkins C.D., Klerman G.L., Williams G.H. The effects of antihypertensive therapy on the quality of life. N. Engl. J. Med. 314:1986;1657-1664.
7. Crook T., Bartus R.T., Ferris S.H., Whitehouse P., Cohen G.D., Gershon S. Age-associated memory impairment. Proposed diagnostic criteria and measures of clinical change. Dev. Neuropsychol. 24:1986;261-271.
8. Erdös E., Skidgel R.A. The angiotensin I-converting enzyme. Lab. Invest. 56:1987;345-348.
9. Fogarty D.G., Maxwell A.P., Doherty C.C., Hugues A.E., Nevin N.C. ACE gene typing. Lancet. 343:1994;851.
10. Folstein M.F., Folstein S.E., McHugh P. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
11. Mayeux R., Saunders A.M., Shea S., Mirra S., Evans D., Roses A.D., Hyman B.T., Crain B., Tang M.X., Phelps C.H. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N. Engl. J. Med. 338:1998;506-511.
12. Markus H.S., Barley J., Lunt R., Bland J.M., Jeffrey S., Carter N.D., Brown M.M. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke. 26:1995;1329-1333.
13. Hachinski V.C., Illif L.D., Zilkha E., DuBoulay G.M., Mc Allister V.L., Marshall J., Russel R.W., Symon L. Cerebral blood flow in dementia. Arch. Neurol. 32:1975;632-637.
14. McKhann G., Drachmann D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
15. Palumbo B., Parnetti L., Nocentini G., Cardinali L., Brancorsini S., Riccardi C., Senin U. Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. Neurosci. Lett. 231:1997;59-61.
16. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A., Moody D.M., O'Brien M.D., Yamaguchi T., Grafman J., Drayer P.B., Bennett D.A., Fischer M., Ogata J., Kokmen E., Bermejo F., Wolf P.A., Gorelick P.B., Bick K.L., Pajeau A.K., Bell M.A., De Carli C., Culabras A., Korczyn A.D., Bogousslavski J., Hartmann A., Scheinberg P. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 43:1993;250-260.
17. Tiret L., Rigat B., Visikis S., Breda C., Corvol P., Cambien F., Soubrier F. Evidence from combined segragation and linkage analysis that a variant of the angiotensin converting enzyme gene controls plasma ACE levels. Am. J. Hum. Genet. 51:1992;197-205.